1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with Shock, Septic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruetten, H; Thiemermann, C; Vane, JR | 1 |
1 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Shock, Septic
| Article | Year |
|---|---|
Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat.
Topics: Acid-Base Equilibrium; Anesthesia; Animals; Blood Gas Analysis; Blood Pressure; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Hemodynamics; Indans; Interferon-gamma; Kidney; Lipopolysaccharides; Liver; Male; Norepinephrine; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Shock, Septic; Tumor Necrosis Factor-alpha | 1996 |